FUTURE OF HEALTHCARE

Medtronic and DaVita Together Launch a New Kidney Health Tech Company

Medtronic plc | May 27, 2022

Medtronic and DaVita

Medtornic, the Dublin-based leading provider of healthcare technology, announced a partnership with DaVita, a premier national provider focused on kidney health. Through the partnership, both organizations aim to form a medical device company called NewCo that specializes in kidney care.

"This is an exciting moment that will shape the future of kidney care. Our singular focus on end-to-end kidney health solutions will position this new company to make a measurable difference in the lives of more than three million patients with kidney failure globally—a figure expected to double over the next decade."

Ven Manda, president of Medtronic's RCS business and NewCo's CEO

By combining Medtronic’s proficiency in healthcare technology with DaVita’s extensive expertise in holistic kidney care solutions. NewCo will emphasize the development of cutting-edge kidney care products.” “The firm is well-positioned to further the promotion of differentiated kidney therapies.

"We're excited to collaborate with Medtronic and share our deep insight into patient and physician needs with the goal of accelerating the development and commercialization of scalable kidney care technologies. DaVita is committed to best-in-class solutions that improve outcomes, access, and the quality of life of our patients, and this is another way to provide more options to the market."
Javier Rodriguez, CEO of DaVita
 

Spotlight

As the cigarette influence a woman's life?  In this fifth episode about smoking and its effects, you can check the influence of smoking in women's lives.  Women are equally or more susceptible to the harmful effects of smoking than men, check out the video.

Spotlight

As the cigarette influence a woman's life?  In this fifth episode about smoking and its effects, you can check the influence of smoking in women's lives.  Women are equally or more susceptible to the harmful effects of smoking than men, check out the video.

Related News

HEALTH TECHNOLOGY

Trukera™ Medical Launches New ScoutPro™ Osmolarity System

Trukera Medical | September 13, 2022

Trukera™ Medical last week announced a corporate rebranding to reflect thea company’s expanded vision and strategic growth plans targeting broader unmet needs in corneal health. Trukera Medical unveiled the first product under the new company name, the ScoutPro™ Osmolarity System. Designed to help advance corneal health decisions for today’s busy eye care practices, ScoutPro is the first and only portable osmometer in the U.S. “The ScoutPro Osmolarity System is an exciting technology developed around the evolving needs of today’s eye care professionals. Premium cataract and refractive practices are now the fastest growing adopters of osmolarity testing, given the prevalence of hyperosmolarity in their patient demographics and the risk it poses to compromising corneal cell health and driving refractive instability. More than ever, these practices require patient care solutions that can seamlessly adapt into established operational models, not the other way around, to deliver a premium patient experience, efficiency of care, and minimize staff time and disruptions. We’re proud to bring a solution to market addressing these needs, and to help more practices objectively identify and manage such a critical component to patient’s corneal health and refractive outcomes.” Adam Szaronos, Trukera Medical CEO The ScoutPro Osmolarity System brings together nanoliter volume sample collection and analysis in a single portable device. Users can now bring laboratory testing to patients anywhere in the practice to quickly test and provide objective results in the palm of their hand. The system is built upon the company’s established accuracy trusted in over 24 million tests globally to date, with an industry-leading precision. “Toxic hyperosmolarity damages sensitive corneal nerves and may cause refractive instability. As cornea and cataract/refractive specialists, we are cognizant of the importance of this to our surgical outcomes and the overall health of our patients’ eyes. ScoutPro gives us the ability to precisely determine osmolarity quickly and easily, without disrupting patient flow,” said Dr. Lisa Nijm, Chief Medical Advisor for Ophthalmology at Trukera Medical and Corneal Surgeon at Warrenville Eye Care and LASIK Center in Illinois. The ScoutPro Osmolarity System is now available for pre-order in the U.S. and will be commercially launched at the upcoming World Cornea Congress and the American Academy of Ophthalmology later this month. About Trukera Medical Trukera Medical is a global leader in developing and marketing comprehensive corneal health technologies. The company introduced tear osmolarity testing to eye care with its flagship device, the TearLab Osmolarity System, which has been used over 24 million times worldwide. Trukera Medical’s expanding portfolio includes ScoutPro, the first and only portable osmolarity system in the U.S. The company’s dedicated focus is improving corneal health, both as a primary goal and in preparation for surgery.

Read More

HEALTH TECHNOLOGY

Viveon Health Acquisition Corp. Announces Filing of Registration Statement on Form S-4 in Connection with Suneva Medical

Viveon Health Acquisition Corp. | July 16, 2022

Viveon Health Acquisition Corp. a special purpose acquisition company, and Suneva Medical, Inc. an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic treatments, announced that VHAQ filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission on July 13, 2022. The Registration Statement, contains a preliminary proxy statement/prospectus in connection with the previously announced business combination between VHAQ and Suneva. While the information within the Registration Statement is subject to change, it provides important information about Suneva Medical and VHAQ, as well as the proposed business combination. On January 12, 2022, VHAQ entered into a merger agreement with Suneva. The combined company is expected to be listed on the NYSE American upon completion of the transaction, which is expected to occur in the second half of 2022, subject to approval by VHAQ’s shareholders, the Registration Statement being declared effective by the SEC, and other customary closing conditions. Included in the Registration Statement are Suneva’s financial results for 2021 and for the first quarter of 2022. Overall, Suneva delivered strong revenue growth in 2021 and generated $29.5 million of net sales and $6.3 million in Q1 of 2022. Suneva’s full financial results and related disclosures can be found in the Registration Statement. About Suneva Medical, Inc. Suneva Medical, Inc., headquartered in San Diego, CA, is a leader in regenerative aesthetics. It is focused on developing, manufacturing and commercializing branded products for providers and their patients. Suneva offers a portfolio of products to address the impact of the aging process to deliver solutions that leverage the body’s own restorative capacity. The product portfolio is composed of several “only” and “first to market” solutions with both FDA PMA approval and 510(k) clearance. About Viveon Health Acquisition Corp. Viveon Health Acquisition Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Read More

HEALTH TECHNOLOGY

SWORD HEALTH LAUNCHES A NEW BRAND THAT EMBODIES ITS VISION TO FREE THE WORLD FROM PAIN

SWORD Health | July 05, 2022

Sword Health, the fastest growing digital musculoskeletal (MSK) solution on the market, announced that it is launching a new brand that reflects its mission to free 2 billion people from pain. This change comes at an immense time of progress for the company as it sets its sights on growth in 2023. The new brand position is communicated through a redesigned institutional as well as a modernized logomark composed of two circular shapes representing the company’s focus on every member’s unique journey to a healthier life – the outlined circle represents prevention, and the filled circle treatment. The company will also be softening the look and feel of its digital applications, including the digital therapist and member app. Additionally, its color palette, iconography, photography, member experience, and apparel have all undergone a strategic upgrade to reflect the evolution of Sword Health. "We are announcing the beginning of a global movement to free the world from pain. It's more than just a new look and feel to us, it's the culmination of years of research and development, aimed at supporting the core goal of healing people’s pain. We're confident this movement expresses both the transformation of our company as a whole and the future of a pain-free world." Virgilio Bento, Founder and CEO of SWORD Health Sword Health believes in the power of people to recover at home, without resorting to surgeries or opioids. Since launching in 2015, Sword Health has worked with insurers, health systems and employers worldwide to make high quality physical care accessible to everyone. Sword Health is setting a new standard for clinical outcomes: the company’s results are of a higher quality than the traditional model, and it is delivering real cost savings to their customers while helping their employees heal quickly and safely. About Sword Health Sword Health is the world’s fastest growing digital musculoskeletal (MSK) care provider, on a mission to free 2 billion people from acute, chronic, and post-surgical pain. It is the first digital solution to pair its members with a licensed physical therapist and the Sword Health Digital Therapist, to deliver a clinically-proven, personalized treatment plan that is more effective, easier, and less expensive than the traditional gold standard of care. Sword Health believes in the power of people to recover at home, without resorting to imaging, surgeries or opioids. With the preventative care delivered through Sword+, it is the industry's only end-to-end digital MSK solution. Since launching in 2015, Sword Health has worked with insurers, health systems, and employers in the U.S., Canada, Europe, and Australia to make high quality musculoskeletal care accessible to everyone.

Read More